durvalumab,medi1191
astrazeneca
['deliver,(-delivered),(-delivery),(-delivers),(-delivering)', 'durva', 'medi1191', 'hcc', 'solid tumor']
eduardo castanon of provides an update on it medi1191 + durvalumab, a first-in-human study in advanced solid tumors, at #aacr23. read this #jitc research on lipid nanoparticles that deliver il-12 mrna in myc oncogene-driven hcc. 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)